Entity is a member of the group.


OUR VISIONLive better longer

With Entity’s pioneering drug formulation, development and regulatory experts, we seek to develop therapies and products that combat the ravages of aging and improve quality of life for those with chronic illnesses and debilitating conditions. Allowing you to become the healthiest, happiest version of yourself – amplified by science.

OUR MISSIONCreated by science,
perfected by experts

We thrive to combine innovative formulations and delivery systems to bring you science based nutraceuticals that improve your health right down to a cellular level. All designed by our team of in-house specialists in medicine, pharmacy, drug delivery and nutrition to restore your body from inside out. Age is just a number; life is as exciting as before.


Entity has a dynamic team of scientists and creatives who are passionate about innovations in healthcare and lifestyle. We are currently based in Singapore, Hong Kong, Shanghai and Australia.

  • Dr Cook co-directs research and product development at Entity. He has more than 30 years of experience in the analysis of complex pharmaceutical and biological samples. Dr Cook earned his PhD in Nuclear Magnetic Resonance and Synthetic Organic Chemistry from La Trobe University.
    Dr Iain Cook, PhD
    Chief Scientist
  • Dr Lim co-directs research and product development at Entity. He has more than 30 years of teaching and research experience in pharmacy, drug formulation and stability. An Adjunct Associate Professor in the School of Pharmacy at Curtin University, Dr Lim earned his PhD in Pharmacy from the same University.
    Dr Stephen Lim, PhD
    Chief Pharmacist
  • Dr Yang oversees all analytical testing for Entity through method development, method transfer and method validation. He has over 30 years of experience in the method development and validation of complex clinical and pharmaceutical methods. Dr Yang earned his PhD in Analytical chemistry from the Victoria University of Technology.
    Dr Lin Yang, PhD
    Research Scientist
  • Eva directs the overall vision for Entity, including user experience, product design and marketing campaigns. Eva earned her LLB at the National University of Singapore and was previously a lawyer with a leading law firm in Singapore.
    Eva Tan
    Commercial Director
  • Desiree oversees all operations and regulatory compliance elements at Entity. Previously, she was a management consultant at PricewaterhouseCoopers LLP. Desiree earned her BBM and BAcc at Singapore Management University.
    Desiree Chua
    Senior Manager, Business Development
  • Ziwei runs our business development activities in Shanghai, China. Ziwei earned her BBM at The Ohio State University.
    Ziwei Su
    Business Development Manager
  • Grammy runs our business development activities in Melbourne, Australia. Grammy earned her BPharm at The University of Auckland and is a certified pharmacist in Australia.
    Grammy Ngai
    Corporate Marketing Executive

Scientific Advisors

  • Dr Krishnarajah, a consultant physician specialising in Clinical Pharmacology and Internal medicine, is the Chief Medical Officer at iX Biopharma. He is responsible for the development and implementation of iX Biopharma’s clinical trial programmes. Dr Krishnarajah earned his MBBS at The University of Western Australia and is a Fellow of the Royal Australasian College of Physicians.
    Dr Janakan Krishnarajah, MBBS, FRACP
    Medical Practitioner

HOW WE’RE DIFFERENTUnique to you and your condition

We don’t believe in a one-size-fits-all kind of approach in health supplements. At Entity, we’ve harnessed the latest advancements in science to bring you a line of the finest nutraceuticals individually targeted to a wide range of conditions – all so you can feel your very best in a real, tangible way. No guesswork, no hoping for the best. We ensure that what you put in your body does exactly what you want it to – and nothing else.

WAFERIX® TECHNOLOGYPatented Delivery – as featured in our LumeniX® and WafeRest® products

WaferiX® is a patented sublingual (that’s science speak for under the tongue) wafer technology. The wafer dissolves in the sublingual space within a minute, allowing for rapid absorption directly into the adjacent blood vessels through the thin mucosal membrane.

WAFERIX® TECHNOLOGYThe beneficial characteristics of WaferiX® include

  • Rapid disintegration within one minute
  • Rapid absorption and onset of therapeutic action
  • Higher bioavailability due to reduced hepatic first pass metabolism (bypassing the digestive G.I. tract)
  • Well tolerated with no after-taste and gritty feeling
  • Non-invasive